| Avrobio Raises $60M for Fabry Disease Gene Therapy, Rest of Pipeline | Frank Vinluan | 02/01/18 | Boston |
| Inozyme Gets $49M From Sanofi, Novo to Tackle Rare Infant Disease | Ben Fidler | 11/15/17 | Boston |
| Amicus Therapeutics’ Pompe Drug Data Show Improved Muscle Movement | Frank Vinluan | 10/04/17 | New York |
| At Long Last, First Drug Approval in Sight for Amicus | Ben Fidler | 04/01/16 | New York |
| Alexion Shells Out $8.4B for Synageva In Rare Disease Mega-Deal | Ben Fidler | 05/06/15 | Boston |
| With Persistence And Phase 3 Win, Amicus Nears First Drug Approval | Ben Fidler | 08/20/14 | New York |
| Amicus Shelves New-Drug Filing For Fabry Disease Drug | Ben Fidler | 06/17/13 | New York |
| Genzyme Says Supplies, Sales of Two Enzyme Drugs Will Be Even Lower Than Previously Predicted | Wade Roush | 09/23/09 | Boston |
